Projects per year
Fingerprint
- 1 Similar Profiles
Network
-
Mayo Clinic Hepatobiliary SPORE
Mc Niven, M. A., Mandrekar, S. J., Torbenson, M., Gores, G. J., Alberts, S. R., Vile, R. G., Leof, E. B., Roberts, L. R., Roberts, L. R. & Gores, G. J.
9/10/18 → 8/31/22
Project: Research project
-
Alliance Statistics and Data Management Center
Mandrekar, S. J., Sargent, D. J. & Sargent, D. J.
4/17/14 → 2/28/23
Project: Research project
-
Methodology for development, validation, and use of novel endpoints in oncology
Sargent, D. J., Mandrekar, S. J. & Sargent, D. J.
2/1/14 → 1/31/20
Project: Research project
-
Validation of New Tumor Measurement-based Phase II Clinical Trial Endpoints
An, M. W. & Mandrekar, S. J.
4/1/12 → 3/31/13
Project: Research project
Research output
-
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA
ANSELMA collaborative group, May 2022, In: European Journal of Cancer. 166, p. 112-125 14 p.Research output: Contribution to journal › Review article › peer-review
-
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy among Patients with Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)
Kehl, K. L., Zahrieh, D., Yang, P., Hillman, S. L., Tan, A. D., Sands, J. M., Oxnard, G. R., Gillaspie, E. A., Wigle, D., Malik, S., Stinchcombe, T. E., Ramalingam, S. S., Kelly, K., Govindan, R., Mandrekar, S. J., Osarogiagbon, R. U. & Kozono, D., May 2022, In: JAMA Oncology. 8, 5, p. 717-728 12 p.Research output: Contribution to journal › Article › peer-review
-
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202
Ruppert, A. S., Booth, A. M., Ding, W., Bartlett, N. L., Brander, D. M., Coutre, S., Brown, J. R., Nattam, S., Larson, R. A., Erba, H., Litzow, M., Owen, C., Kuzma, C. S., Abramson, J. S., Little, R. F., Smith, S. E., Stone, R. M., Byrd, J. C., Mandrekar, S. J. & Woyach, J. A., Oct 2021, In: Leukemia. 35, 10, p. 2854-2861 8 p.Research output: Contribution to journal › Article › peer-review
-
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia
Cheung, M. C., Mittmann, N., Owen, C., Abdel-Samad, N., Fraser, G. A. M., Lam, S., Crump, M., Sperlich, C., van der Jagt, R., Prica, A., Couban, S., Woyach, J. A., Ruppert, A. S., Booth, A. M., Mandrekar, S. J., McDonald, G., Shepherd, L. E., Yen, H., Chen, B. E. & Hay, A. E., Nov 2021, In: Clinical Lymphoma, Myeloma and Leukemia. 21, 11, p. 766-774 9 p.Research output: Contribution to journal › Article › peer-review
-
Impact of the COVID-19 Pandemic on Cancer Clinical Trials
Boughey, J. C., Snyder, R. A., Kantor, O., Zheng, L., Chawla, A., Nguyen, T. T., Hillman, S. L., Hahn, O. M., Mandrekar, S. J. & Roland, C. L., Nov 2021, In: Annals of surgical oncology. 28, 12, p. 7311-7316 6 p.Research output: Contribution to journal › Article › peer-review